Literature DB >> 8940966

Dynamics and control of Schistosoma haematobium transmission in Kenya: an overview of the Msambweni Project.

E M Muchiri1, J H Ouma, C H King.   

Abstract

Ecologic modeling of Schistosoma transmission in endemic communities has suggested that antiparasite therapy targeted at the most heavily infected segment of the human population (i.e., school-age children) should have a significant impact on local parasite transmission. Our 1984-1991 experience with age-targeted therapy in the Msambweni area of Kenya has shown an overall decrease in area transmission within 1-2 years following initiation of annual treatment of school-age groups. Snail monitoring confirmed a continuing but variable reduction of vector infection rates. However, subgroup analysis showed significant differences in transmission suppression between more developed coastal villages with piped-water kiosks and villages with only limited access to safe water supplies. Villages without piped water were marked by higher initial prevalences of S. haematobium infection, greater prevalence among adults, longer and more frequent contact with high-risk water sources, and persistently high transmission despite compliance with parasitologic screening or drug therapy. We conclude that targeted therapy had a significant impact on S. haematobium transmission in some areas, but that more extensive or more prolonged coverage is necessary to reduce the rate of new infection in high-risk villages. Defining field-use algorithms, based on decision analysis of economic and ecologic parameters, should provide effective guidelines for selective versus mass treatment in expanded control areas.

Entities:  

Mesh:

Year:  1996        PMID: 8940966     DOI: 10.4269/ajtmh.1996.55.127

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Impact of drought on the spatial pattern of transmission of Schistosoma haematobium in coastal Kenya.

Authors:  Francis M Mutuku; Charles H King; Amaya L Bustinduy; Peter L Mungai; Eric M Muchiri; Uriel Kitron
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Human schistosomiasis haematobium: effective diagnosis of active infection using a pair of monoclonal antibodies against soluble egg antigen.

Authors:  F Salah; A El Bassiouny; I Rabia; Z Demerdash; M Roshdy; Z Shaker
Journal:  Parasitol Res       Date:  2006-04-22       Impact factor: 2.289

3.  A new approach to modelling schistosomiasis transmission based on stratified worm burden.

Authors:  D Gurarie; C H King; X Wang
Journal:  Parasitology       Date:  2010-07-13       Impact factor: 3.234

4.  Evaluating the potential impact of mass praziquantel administration for HIV prevention in Schistosoma haematobium high-risk communities.

Authors:  Martial L Ndeffo Mbah; Jennifer A Gilbert; Alison P Galvani
Journal:  Epidemics       Date:  2014-04-29       Impact factor: 4.396

5.  Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program.

Authors:  Sudtida A Satayathum; Eric M Muchiri; John H Ouma; Christopher C Whalen; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2006-07       Impact factor: 2.345

Review 6.  Kidney disease among children in sub-Saharan Africa: systematic review.

Authors:  Neema M Kayange; Luke R Smart; Jacob E Tallman; Emily Y Chu; Daniel W Fitzgerald; Kevin J Pain; Robert N Peck
Journal:  Pediatr Res       Date:  2014-11-24       Impact factor: 3.756

7.  Upscale or downscale: applications of fine scale remotely sensed data to Chagas disease in Argentina and schistosomiasis in Kenya.

Authors:  Uriel Kitron; Julie A Clennon; M Carla Cecere; Ricardo E Gürtler; Charles H King; Gonzalo Vazquez-Prokopec
Journal:  Geospat Health       Date:  2006-11       Impact factor: 1.212

Review 8.  Parasites and poverty: the case of schistosomiasis.

Authors:  Charles H King
Journal:  Acta Trop       Date:  2009-12-04       Impact factor: 3.112

9.  Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection.

Authors:  Xiaoxia Wang; David Gurarie; Peter L Mungai; Eric M Muchiri; Uriel Kitron; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2012-11-15

Review 10.  Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review.

Authors:  Charles H King; Stephanie K Olbrych; Margaret Soon; Mendel E Singer; Jen Carter; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2011-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.